Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee

---
identifier: "/us/fr/04-4687"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee"
title_number: 0
title_name: "Federal Register"
section_number: "04-4687"
section_name: "Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee"
positive_law: false
currency: "2004-03-03"
last_updated: "2004-03-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Office of National Drug Control Policy"
document_number: "04-4687"
document_type: "notice"
publication_date: "2004-03-03"
agencies:
  - "Office of National Drug Control Policy"
fr_citation: "69 FR 10065"
fr_volume: 69
fr_action: "Notice of Meeting."
---


#  Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee

**AGENCY:**

Office of National Drug Control Policy.

**ACTION:**

Notice of Meeting.

**SUMMARY:**

The Drug Control Research, Data, and Evaluation Advisory Committee will meet to discuss federal drug control initiatives, ONDCP's three strategic priorities: Stopping Drug Use Before it Starts; Healing America's Drug Users; and Disrupting the Market, and the operational aspects of the: (1) Media Campaign; (2) 25 Cities Initiative; (3) Marijuana Initiative; (4) Domestic Market Disruption; (5) Student Drug Testing; (6) Prescription Drug Safety; (7) Colombia/Mexico; and (8) Access to Recovery.

**DATES:**

The meeting will be held Thursday, April 1, through Friday, April 2, 2004 each day from 9 a.m. to 4 p.m. There will be an opportunity for public comment on April 1st from 3:30 p.m. to 4 p.m.

**ADDRESSES:**

The meeting will be held at the Office of National Drug Control Policy, 750 17th Street, NW., 5th Floor Conference Room, Washington, DC.

**FOR FURTHER INFORMATION CONTACT:**

Janie Dargan, (202) 395-6714.

Dated: February 27, 2004.

Daniel R. Petersen,

Assistant General Counsel.